Galapagos | GLPG - Stammkapital

Aktienkurs
24.66
Täglich Wechseln
0.66 2.75%
Monatlich
-13.41%
Jährlich
16.65%
Q2 Prognose
23.83




Stammkapital Veränderung Datum
AstraZeneca USD 1.55B 206K 2025-12
Biogen USD 146.7M 200K 2025-09
Genmab DKK 61.62M 52K 2025-12
Gilead Sciences USD 1.24B 1000K 2025-12
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
GRIFOLS EUR 680.58M 846K 2025-12
Hikma Pharmaceutical USD 221.89M 181.89M 2025-12
Incyte USD 198.46M 2.33M 2025-12
Merck EUR 434.78M 0 2025-12
Neurocrine Biosciences USD 100.1M 400K 2025-12
Novartis USD 1.91B 10.64M 2025-12
Roche Holding CHF 795.62M 699.54K 2025-12
UCB EUR 190.36M 365.15K 2025-12
Vertex Pharmaceuticals USD 254M 0 2025-12